<seo title="Organon & Co." metakeywords="organon multinational pharmaceutical,organon publicly traded,organon business,organon financial performance" metadescription="Organon & Co. is a multinational pharmaceutical company headquartered in the Netherlands." />
===Introduction to Organon & Co.===

Organon & Co. is a multinational pharmaceutical company headquartered in the Netherlands. Founded in 1923, the company has grown to become one of the world’s leading pharmaceutical companies, with operations in over 100 countries. Organon & Co. is a publicly traded company, listed on the Euronext Amsterdam stock exchange. The company’s products include prescription drugs, over-the-counter medications, and medical devices.
===History of Organon & Co.===

Organon & Co. was founded in 1923 by Dutch physician and entrepreneur Dr. Willem J. Kolff. Dr. Kolff was a pioneer in the field of dialysis and developed the first artificial kidney. He also developed the first artificial heart and the first artificial heart-lung machine. In the 1950s, Organon & Co. began to expand its operations, entering the pharmaceutical industry. The company developed a number of innovative drugs, including the first oral contraceptive pill. In the 1970s, the company began to expand its operations into the United States and other countries.
===Organon & Co.’s Financial Performance===

Organon & Co. has had a strong [[Financial Performance|financial performance]] over the past decade. The company’s revenue has grown steadily, reaching €14.3 billion in 2020. The company’s [[Net Income|net income]] has also grown, reaching €1.2 billion in 2020. The company’s stock price has also increased significantly over the past decade, reaching a high of €50.50 in 2020.
===Organon & Co.’s Business Model===

Organon & Co.’s business model is focused on developing and marketing innovative pharmaceutical products. The company has a strong research and development team, which is responsible for developing new drugs and medical devices. The company also has a strong marketing team, which is responsible for promoting the company’s products. The company also has a strong distribution network, which is responsible for distributing the company’s products to customers.
===Organon & Co.’s Impact on the Economy===

Organon & Co. has had a significant impact on the global economy. The company’s products have helped to improve the health and well-being of millions of people around the world. The company’s products have also helped to create jobs and stimulate [[Economic Growth|economic growth]] in many countries. The company’s research and development activities have also helped to spur innovation and technological advancement in the pharmaceutical industry.
===Conclusion===

Organon & Co. is a leading multinational pharmaceutical company that has had a significant impact on the global economy. The company has had a strong financial performance over the past decade, with revenue and net income increasing significantly. The company’s business model is focused on developing and marketing innovative pharmaceutical products, and the company has had a significant impact on the global economy